Cargando…

Application of WHO International Biological Reference Standards to evaluate commercial serological tests for chronic Chagas disease

BACKGROUND: Chagas disease, resulting from Trypanosoma cruzi infections, continues to be a health concern mainly in Latin American countries where the parasite is endemic. The laboratory diagnosis of a chronic infection is determined through serological assays for antibodies against T. cruzi and sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sáez-Alquezar, Amadeo, Junqueira, Angela Cristina Verissimo, Durans, Andressa da Matta, Guimarães, André Valpassos, Corrêa, José Abol, Provance, D William, Cabello, Pedro Hernan, Coura, José Rodrigues, Viñas, Pedro Albajar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379854/ https://www.ncbi.nlm.nih.gov/pubmed/32725060 http://dx.doi.org/10.1590/0074-02760200214

Ejemplares similares

Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG
por: Sáez-Alquezar, Amadeo, et al.
Publicado: (2021)

Quality Control in Screening for Infectious Diseases at Blood Banks. Rationale and Methodology
por: Sáez-Alquezar, Amadeo, et al.
Publicado: (2015)

Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries
por: Coura, José Rodrigues, et al.
Publicado: (2014)

Morbidity of Chagas heart disease in the microregion of Rio Negro, Amazonian Brazil: a case-control study
por: Coura, José Rodrigues, et al.
Publicado: (2013)

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
por: Machado-de-Assis, Girley Francisco, et al.
Publicado: (2013)

Performance assessment of a multi-epitope chimeric antigen for the serological diagnosis of acute Mayaro fever
por: Napoleão-Pêgo, Paloma, et al.
Publicado: (2021)

Acute Chagas disease in the state of Pará, Amazon Region: is it increasing?
por: dos Santos, Valéria Regina Cavalcante, et al.
Publicado: (2018)

Surveillance of seroepidemiology and morbidity of Chagas disease in the Negro River, Brazilian Amazon
por: Coura, José Rodrigues, et al.
Publicado: (2018)

Surveillance, health promotion and control of Chagas disease in the Amazon Region - Medical attention in the Brazilian Amazon Region: a proposal
por: Coura, José Rodrigues, et al.
Publicado: (2015)

Nicastrin-Like, a Novel Transmembrane Protein from Trypanosoma cruzi Associated to the Flagellar Pocket
por: Lechuga, Guilherme Curty, et al.
Publicado: (2021)

Special issue on Chagas disease
por: Coura, José Rodrigues
Publicado: (2015)

Preanalytical Nonconformity Management Regarding Primary Tube Mixing in Brazil
por: Lima-Oliveira, Gabriel, et al.
Publicado: (2017)

Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay
por: Bottino, Carolina G, et al.
Publicado: (2013)

Chagas disease: control, elimination and eradication. Is it possible?
por: Coura, José Rodrigues
Publicado: (2013)

Health Policies to Control Chagas Disease Transmission in European Countries
por: Requena-Méndez, Ana, et al.
Publicado: (2014)

Congenital Chagas Disease: Recommendations for Diagnosis, Treatment and Control of Newborns, Siblings and Pregnant Women
por: Carlier, Yves, et al.
Publicado: (2011)

Clinical Follow-Up of Responses to Treatment with Benznidazol in Amazon: A Cohort Study of Acute Chagas Disease
por: Pinto, Ana Yecê das Neves, et al.
Publicado: (2013)

The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions - A comprehensive review
por: Coura, José Rodrigues
Publicado: (2015)

Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières
por: Yun, Oliver, et al.
Publicado: (2009)

Human acute Chagas disease: changes in factor VII, activated protein C and hepatic enzymes from patients of oral outbreaks in Pará State (Brazilian Amazon)
por: dos Santos, Valéria Regina Cavalcante, et al.
Publicado: (2020)

Controlling congenital and paediatric chagas disease through a community health approach with active surveillance and promotion of paediatric awareness
por: Soriano-Arandes, Antoni, et al.
Publicado: (2014)

Comparative evaluation of community interventions for the immigrant population of Latin American origin at risk for Chagas disease in the city of Barcelona
por: Gómez i Prat, Jordi, et al.
Publicado: (2020)

Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women
por: Carlier, Yves, et al.
Publicado: (2019)

How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day
por: de Oliveira, Wilson Alves, et al.
Publicado: (2022)

Conventional serological performance in diagnosis of Chagas’ disease in southern Brazil
por: Araújo, Anelise Bergmann, et al.
Publicado: (2013)

Community-based actions in consulates: a new paradigm for opportunities for systematic integration in Chagas disease detection
por: Gómez i Prat, Jordi, et al.
Publicado: (2023)

Diagnostic performance of commercially available COVID-19 serology tests in Brazil
por: Cota, Gláucia, et al.
Publicado: (2020)

Cross-sectional, descriptive study of Chagas disease among citizens of Bolivian origin living in Munich, Germany
por: Navarro, Miriam, et al.
Publicado: (2017)

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease
por: Viotti, Rodolfo, et al.
Publicado: (2011)

Longitudinal follow up of serological response in children treated for Chagas disease
por: Moscatelli, Guillermo, et al.
Publicado: (2019)

Chagas Disease Serological Test Performance in U.S. Blood Donor Specimens
por: Whitman, Jeffrey D., et al.
Publicado: (2019)

Prevalence, Clinical Staging and Risk for Blood-Borne Transmission of Chagas Disease among Latin American Migrants in Geneva, Switzerland
por: Jackson, Yves, et al.
Publicado: (2010)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease
por: Fragata-Filho, Abilio Augusto, et al.
Publicado: (2016)

From serological surveys to disease burden: a modelling pipeline for Chagas disease
por: Ledien, Julia, et al.
Publicado: (2023)

Development of Peptide-Based Lineage-Specific Serology for Chronic Chagas Disease: Geographical and Clinical Distribution of Epitope Recognition
por: Bhattacharyya, Tapan, et al.
Publicado: (2014)

Chagas disease in Virgem da Lapa, Minas Gerais, Brazil: left ventricle aneurysm and the risk of death in the 24-year interval
por: Borges-Pereira, José, et al.
Publicado: (2020)

Endemic Diseases: Globalization, Urbanization, and Immunosuppression
por: Shikanai Yasuda, Maria Aparecida, et al.
Publicado: (2013)

TGF-β Polymorphisms Are a Risk Factor for Chagas Disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2018)

COVID-19: an opportunity of systematic integration for Chagas disease. Example of a community-based approach within the Bolivian population in Barcelona
por: Gómez i Prat, Jordi, et al.
Publicado: (2022)

FC-TRIPLEX Chagas/Leish IgG1: A Multiplexed Flow Cytometry Method for Differential Serological Diagnosis of Chagas Disease and Leishmaniasis
por: Teixeira-Carvalho, Andréa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9klttguc3dj43a6p5jolee0pd2